Osteoporosis: Emerging Targets on the Classical Signaling Pathways of Bone Formation

Eur J Pharmacol. 2024 Apr 18:176574. doi: 10.1016/j.ejphar.2024.176574. Online ahead of print.ABSTRACTOsteoporosis is a multifaceted skeletal disorder characterized by reduced bone mass and structural deterioration, posing a significant public health challenge, particularly in the elderly population. Treatment strategies for osteoporosis primarily focus on inhibiting bone resorption and promoting bone formation. However, the effectiveness and limitations of current therapeutic approaches underscore the need for innovative methods. This review explores emerging molecular targets within crucial signaling pathways, including wingless/integrated (WNT), bone morphogenetic protein (BMP), hedgehog (HH), and Notch signaling pathway, to understand their roles in osteogenesis regulation. The identification of crosstalk targets between these pathways further enhances our comprehension of the intricate bone metabolism cycle. In summary, unraveling the molecular complexity of osteoporosis provides insights into potential therapeutic targets beyond conventional methods, offering a promising avenue for the development of new anabolic drugs.PMID:38642670 | DOI:10.1016/j.ejphar.2024.176574
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research